Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.66 |
| ▸ | ALB | P02768 | 1/20 | 0.54 |
| ▸ | IL2 | P60568 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TACR1 | P25103 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | FPR2 | P25090 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL604816 | 1.00 | CA2 (0.66) | CA2ALBIL2LMNATACR1 | |
| SCHEMBL328475 | 0.87 | MME (0.60) | CA2LMNACA1FOLH1MME | |
| SCHEMBL468823 | 0.87 | MME (0.60) | CA2LMNACA1FOLH1MME | |
| SCHEMBL9787629 | 0.87 | MME (0.60) | CA2LMNACA1FOLH1MME | |
| SCHEMBL29367167 | 0.87 | MME (0.60) | CA2LMNACA1FOLH1MME | |
| SCHEMBL3981526 | 0.85 | CA2 (0.62) | CA2ALBIL2CA1FOLH1 | |
| SCHEMBL27086746 | 0.85 | CA2 (0.61) | CA2ALBIL2CA1FOLH1 | |
| SCHEMBL27086749 | 0.85 | CA2 (0.61) | CA2ALBIL2CA1FOLH1 | |
| SCHEMBL4799488 | 0.84 | LMNA (0.52) | CA2LMNATACR1CA1FOLH1 | |
| SCHEMBL27477803 | 0.84 | LMNA (0.52) | CA2ALBIL2LMNATACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1540341-A4 | METHOD FOR DETERMINATION OF LIKELIHOOD OF OCCURRENCE OF PRETERM LABOR IN PREGNANT FEMALES | UNIV ROCHESTER MEDICAL CT (US) | 2007-01-10 | — | — | EP | claimed |
| US-20060166295-A1 | Method for determination of likelihood of occurrence of preterm labor in pregnant females | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2006-07-27 | — | — | US | claimed |
| EP-1540341-A1 | METHOD FOR DETERMINATION OF LIKELIHOOD OF OCCURRENCE OF PRETERM LABOR IN PREGNANT FEMALES | The University of Rochester Medical Center (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004003555-A1 | METHOD FOR DETERMINATION OF LIKELIHOOD OF OCCURRENCE OF PRETERM LABOR IN PREGNANT FEMALES | UNIVERSITY OF ROCHESTER MEDICAL CENTER (US) | 2004-01-08 | — | — | WO | claimed |
| EP-2299275-B1 | Classification of the oncofetal fibronection level for pregnancy-related indications | ADEZA BIOMEDICAL CORP (US) | 2018-03-07 | — | — | EP | disclosed |
| US-9513298-B2 | Methods for detecting oncofetal fibronectin | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2016-12-06 | — | — | US | disclosed |
| US-20150044708-A1 | Methods for Detecting Oncofetal Fibronectin | HOLOGIC, INC. | 2015-02-12 | — | — | US | disclosed |
| US-8852872-B2 | Methods for detecting oncofetal fibronectin | HOLOGIC, INC. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20130171672-A1 | Methods for Detecting Oncofetal Fibronectin | HOLOGIC, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-8372581-B2 | Methods for detecting oncofetal fibronectin | CYTYC CORPORATION (US) | 2013-02-12 | — | — | US | disclosed |
| US-20120040356-A1 | Methods for Detecting Oncofetal Fibronectin | CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP | 2012-02-16 | — | — | US | disclosed |
| US-7943294-B2 | Methods for detecting oncofetal fibronectin | HOLOGIC, INC. (US) | 2011-05-17 | — | — | US | disclosed |
| US-20060024724-A1 | Oncofetal fibronectin as a marker for health and disease | CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP | 2006-02-02 | — | — | US | disclosed |
| US-6939716-B2 | Method for detecting conditions indicative of sepsis | WASHINGTON UNIVERSITY (US) | 2005-09-06 | — | — | US | disclosed |
| EP-1540341-A1 | METHOD FOR DETERMINATION OF LIKELIHOOD OF OCCURRENCE OF PRETERM LABOR IN PREGNANT FEMALES | The University of Rochester Medical Center (US) | 2005-06-15 | — | — | EP | disclosed |
| EP-1427845-A2 | METHOD FOR DETECTING SEPSIS | Washington University (US) | 2004-06-16 | — | — | EP | disclosed |
| WO-2004003555-A1 | METHOD FOR DETERMINATION OF LIKELIHOOD OF OCCURRENCE OF PRETERM LABOR IN PREGNANT FEMALES | UNIVERSITY OF ROCHESTER MEDICAL CENTER (US) | 2004-01-08 | — | — | WO | disclosed |
| US-20030100122-A1 | Method for detecting conditions indicative of sepsis | WASHINGTON UNIVERSITY | 2003-05-29 | — | — | US | disclosed |
| WO-2003025212-A2 | METHOD FOR DETECTING SEPSIS | WASHINGTON UNIVERSITY (US) | 2003-03-27 | — | — | WO | disclosed |
| US-4745124-A | THIO/ESTER PEPTIDES | UNIVERSITY OF MIAMI (US) | 1988-05-17 | — | — | US | disclosed |